GENEVA, May 18 -- BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. (Building C25, No. 218 Xinghu Street, Bio-BAY, Suzhou Industrial ParkSuzhou, Jiangsu 215123), 博瑞生物医药（苏州）股份有限公司 (中国江苏省苏州市苏州工业园区星湖街218号生物纳米园C25栋) filed a patent application (PCT/CN2025/133148) for "ORAL PHARMACEUTICAL COMPOSITION CONTAINING DUAL RECEPTOR AGONIST OF GIP AND GLP-1 AND USE THEREOF" on Nov 06, 2025. With publication no. WO/2026/098583, the details related to the patent application was published...